ProfileGDS4095 / 228862_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 63% 61% 61% 59% 61% 60% 58% 60% 60% 60% 60% 60% 60% 60% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep15.3552863
GSM709769LY2 SRC1-siRNA tamoxifen treated rep34.9166161
GSM709765LY2 SRC1-siRNA untreated rep35.0153861
GSM709771LY2 SRC1-siRNA untreated rep14.6840359
GSM709772LY2 SRC1-siRNA untreated rep24.9934961
GSM709775LY2 SRC1-siRNA untreated rep44.7503560
GSM709764LY2 control-siRNA tamoxifen treated rep24.501558
GSM709766LY2 control-siRNA tamoxifen treated rep34.733660
GSM709768LY2 control-siRNA tamoxifen treated rep14.8253560
GSM709777LY2 control-siRNA tamoxifen treated rep44.8357160
GSM709770LY2 control-siRNA untreated rep34.8224660
GSM709773LY2 control-siRNA untreated rep14.7309460
GSM709774LY2 control-siRNA untreated rep24.7358960
GSM709776LY2 control-siRNA untreated rep44.7715860